14-3-3 mediates apelin-13-induced enhancement of adhesion of monocytes to human umbilical vein endothelial cells

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 6, 2010, Pages 403-409

  Li, Xin ^a   Zhang, Xianhui ^a   Li, Fang ^a   Chen, Linxi ^a   Li, Lanfang ^a   Qin, Xuping ^a   Gao, Jing ^a   Su, Tao ^a   Zeng, Yixin ^a   Liao, Duanfang ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

14 3 3; Apelin; APJ; Cell adhesion; Endothelial cell; Monocyte; VCAM 1

Indexed keywords

APELIN 13 PEPTIDE; APELIN-13 PEPTIDE; DIFOPEIN; PROTEIN; PROTEIN 14 3 3; SIGNAL PEPTIDE; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BIOSYNTHESIS; CELL ADHESION; CELL LINE; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HUMAN; METABOLISM; MONOCYTE; PHYSIOLOGY; PREGNANCY; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; DRUG EFFECTS;

14-3-3 PROTEINS; CELL ADHESION; CELL LINE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MONOCYTES; PREGNANCY; PROTEINS; SIGNAL TRANSDUCTION; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 77952993554     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq036     Document Type: Article

References (42)

1. O'Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, Kennedy JL and Shi X, et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993, 136: 355-360.
2. Howard AD, McAllister G, Feighner SD, Liu Q, Nargund RP, Van der Ploeg LH and Patchett AA. Orphan G-protein-coupled receptors and natural ligand discovery. Trends Pharmacol Sci 2001, 22: 132-140.
3. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX and Kawamata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998, 251: 471-476.
4. Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C, Winborn KY and Lawrie KW, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 2003, 84: 1162-1172.
5. Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y, Hinuma S and Kitada C, et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 2000, 275: 21061-21067.
6. Wray DW, Nishiyama SK, Harris RA and Richardson RS. Angiotensin II in the elderly: impact of angiotensin II type 1 receptor sensitivity on peripheral hemodynamics. Hypertension 2008, 51: 1611-1616.
7. Backlund M, Paukku K, Daviet L, De Boer RA, Valo E, Hautaniemi S and Kalkkinen N, et al. Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase. Nucleic Acids Res 2009, 37: 2346-2358.
8. Porrello ER, D'Amore A, Curl CL, Allen AM, Harrap SB, Thomas WG and Delbridge LM. Angiotensin II type 2 receptor antagonizes angiotensin II type 1 receptor-mediated cardiomyocyte autophagy. Hypertension 2009, 53: 1032-1040.
9. Gusev K, Domenighetti AA, Delbridge LM, Pedrazzini T, Niggli E and Egger M. Angiotensin II-mediated adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling. Circ Res 2009, 105: 42-50.
10. Liu CH, Li X, Chen LX, Chen F, Pan WN, Feng F and Qin XP, et al. ERK1/2 mediated the vasodilatation of apelin-13 on vascular rings of spontanously hypertensive rat in vitro. Progress in Biochemistry and Biophysics 2009, 36: 1578-1588.
11. Li F, Li L, Qin X, Pan WN, Feng F, Chen F and Zhu B, et al. Apelin-induced vascular smooth muscle cell proliferation: the regulation of cyclin D1. Front Biosci 2008, 13: 3786-3792.
12. Chandrasekaran B, Dar O and McDonagh T. The role of apelin in cardiovascular function and heart failure. Eur J Heart Fail 2008, 10: 725-732.
13. Falcao-Pires I, Goncalves N, Henriques-Coelho T, Moreira-Goncalves D, Roncon-Albuquerque R, Jr and Leite-Moreira AF. Apelin decreases myocardial injury and improves right ventricular function in monocrotalineinduced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009, 296: H2007-H2014.
14. Moore BW and Perez VJ. Specific acidic proteins of the nervous system. In: Carlson FD (ed.), Physiological and Biochemical Aspects of Nervous Integration. Englewood Cliffs: Prentice-Hall, 1967.
15. Cai Q, Lanting L and Natarajan R. Interaction of monocytes with vascular smooth muscle cells regulates monocyte survival and differentiation through distinct pathways. Arterioscler Thromb Vasc Biol 2004, 24: 2263-2270.
16. Chiba S, Tokuhara M, Morita EH and Abe S. TTP Ser245 phosphorylation by AKT is required for binding to 14-3-3. J Biochem 2009, 145: 403-409.
17. Fischer A, Baljuls A, Reinders J, Nekhoroshkova E, Sibilski C, Metz R and Albert S, et al. Regulation of RAF activity by 14-3-3 proteins: RAF kinases associate functionally with both homo-and heterodimeric forms of 14-3-3 proteins. J Biol Chem 2009, 284: 3183-3194.
18. Lin J, Harding A, Giurisato E and Shaw AS. KSR1 modulates the sensitivity of mitogen-activated protein kinase pathway activation in T cells without altering fundamental system outputs. Mol Cell Biol 2009, 29: 2082-2091.
19. Szanto A, Bognar Z, Szigeti A, Szabo A, Farkas L and Gallyas F, Jr. Critical role of bad phosphorylation by Akt in cytostatic resistance of human bladder cancer cells. Anticancer Res 2009, 29: 159-164.
20. Bayat H, Xu S, Pimentel D, Cohen RA and Jiang B. Activation of thromboxane receptor upregulates interleukin (IL)-1beta-induced VCAM-1 expression through JNK signaling. Arterioscler Thromb Vasc Biol 2008, 28: 127-134.
21. Schmidt C, Hulthe J and Fagerberg B. Baseline ICAM-1 and VCAM-1 are increased in initially healthy middle-aged men who develop cardiovascular disease during 6.6 years of follow-up. Angiology 2009, 60: 108-114.
22. Hastings NE, Feaver RE, Lee MY, Wamhoff BR and Blackman BR. Human IL-8 regulates smooth muscle cell VCAM-1 expression in response to endothelial cells exposed to atheroprone flow. Arterioscler Thromb Vasc Biol 2009, 29: 725-731.
23. Norman MU, James WG and Hickey MJ. Differential roles of ICAM-1 and VCAM-1 in leukocyte-endothelial cell interactions in skin and brain of MRL/faslpr mice. J Leukoc Biol 2008, 84: 68-76.
24. Rabquer BJ, Hou Y, Del Galdo F, Gerber ML, Jimenez SA, Seibold JR and Koch AE, et al. The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1. Rheumatology 2009, 48: 734-740.
25. Schroeter MR, Leifheit M, Sudholt P, Heida NM, Dellas C, Rohm I and Alves F, et al. Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ Res 2008, 103: 536-544.
26. Goda S, Imai T, Umehara H, Yoneda O, Inoue H, Nagano Y and Okazaki T, et al. CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and-independent mechanisms. J Immunol 2000, 164: 4313-4320.
27. Bath PM, Booth RF and Hassall DG. Monocyte-lymphocyte discrimination in a new microtitre-based adhesion assay. J Immunol Methods 1989, 118: 59-65.
28. Zhang Q, Yao F, Raizada MK, O'Rourke ST and Sun C. Apelin gene transfer into the rostral ventrolateral medulla induces chronic blood pressure elevation in normotensive rats. Circ Res 2009, 104: 1421-1428.
29. Lavrentyev EN and Malik KU. High glucose-induced Nox1-derived superoxides downregulate PKC-betaII, which subsequently decreases ACE2 expression and ANG(1-7) formation in rat VSMCs. Am J Physiol Heart Circ Physiol 2009, 296: H106-H118.
30. Gallagher PE, Ferrario CM and Tallant EA. Regulation of ACE2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol 2008, 295: H2373-H2379.
31. Rentzsch B, Todiras M, Iliescu R, Popova E, Campos LA, Oliveira ML and Baltatu OC, et al. Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension 2008, 52: 967-973.
32. Letavernier E, Perez J, Bellocq A, Mesnard L, de Castro Keller A, Haymann JP and Baud L. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension. Circ Res 2008, 102: 720-728.
33. Doughan AK, Harrison DG and Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 2008, 102: 488-496.
34. Munoz MC, Giani JF, Mayer MA, Toblli JE, Turyn D and Dominici FP. TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistance. J Endocrinol 2009, 201: 185-197.
35. Hashimoto T, Kihara M, Imai N, Yoshida S, Shimoyamada H, Yasuzaki H and Ishida J, et al. Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis. Am J Pathol 2007, 171: 1705-1712.
36. Hambardzumyan D, Becher OJ, Rosenblum MK, Pandolfi PP, Manova-Todorova K and Holland EC PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev 2008, 22: 436-448.
37. Murillo CA, Rychahou PG and Evers BM. Inhibition of alpha5 integrin decreases PI3K activation and cell adhesion of human colon cancers. Surgery 2004, 136: 143-149.
38. Harokopakis E, Albzreh MH, Martin MH and Hajishengallis G. TLR2 transmodulates monocyte adhesion and transmigration via Rac1-and PI3K-mediated inside-out signaling in response to Porphyromonas gingivalis fimbriae. J Immunol 2006, 176: 7645-7656.
39. Amin MA, Haas CS, Zhu K, Mansfield PJ, Kim MJ, Lackowski NP and Koch AE. Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3kinase, and NFkappaB. Blood 2006, 107: 2252-2261.
40. Kakinuma N, Roy BC, Zhu Y, Wang Y and Kiyama R. Kank regulates RhoA-dependent formation of actin stress fibers and cell migration via 14-3-3 in PI3K-Akt signaling. J Cell Biol 2008, 181: 537-549.
41. Ajjappala BS, Kim YS, Kim MS, Lee MY, Lee KY, Ki HY and Cha DH, et al. 14-3-3 gamma is stimulated by IL-3 and promotes cell proliferation. J Immunol 2009, 182: 1050-1060.
42. van Hemert MJ, Niemantsverdriet M, Schmidt T, Backendorf C and Spaink HP. Isoform-specific differences in rapid nucleocytoplasmic shuttling cause distinct subcellular distributions of 14-3-3 sigma and 14-3-3 zeta. J Cell Sci 2004, 117: 1411-1420.